Player community

CleverTap Recognized in Latest Gartner® Magic Quadrant™ for Personalization Engines

SAN FRANCISCO and MUMBAI,India,Feb. 11,2025-- CleverTap,the all-in-one engagement platform,today announced that they have been positioned by Gartner®as a Niche Playerin the Magic Quadrant™for pe

02-13 CleverTap

Vipshop to Announce Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025

GUANGZHOU,China,Feb. 11,2025--Vipshop Holdings Limited (NYSE: VIPS),a leading online discount retailer for brands in China ("Vipshop" or the "Company"),today announced that it plan

02-13 Vipshop Holdings Limited

Open for Registration: The 3rd China-ASEAN Innovation and Entrepreneurship Competition (CAIEC-3) 2025

KUALA LUMPUR,Malaysia,Feb. 10,2025-- 2025 China – ASEAN Innovation and Entrepreneurship Competition is now calling for applications.

02-13 TusStar Malaysia

Alexandra Hospital develops world's novel A.I. algorithm (with international patent) that enhances accuracy and efficiency of robotic total knee replacement

Newspoints: An A.I. algorithm for robotic total knee replacement (rTKR) has secured an international Patent Cooperation Treaty (PCT) patent[1],that protects this algorithm for robotic total knee repl

02-13 Alexandra Hospital (AH)

Rees Ward Transitions into Key Leadership Role at Bridgewest Group as Operating Partner and General Manager, New Zealand

MIAMI and AUCKLAND,New Zealand,Feb. 12,2025-- Global private investment firm,Bridgewest Group,recognized for developing innovative companies in life sciences,software,and deep tech,is pleased to anno

02-13 Bridgewest Group

From O Levels to a Medicine, Dentistry or Law Degree in Just 9 Months

SINGAPORE,Feb. 11,2025-- With the growing demand for doctors,Singapore has increased the number of recognised foreign medical schools and ambitious students aiming for careers in medicine,dentistry or

02-13 East Asia Institute of Management (EAIM)

NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare

Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM.

02-13 Paradromics

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC

HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult

02-13 Akeso, Inc.

WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year

Ranked among the top 1% of companies assessed in the pharmaceutical industry Recognized as a leader in Green CRDMO,driving innovation for a healthier future

02-11
Home Previous 25 26 27 28 29 30 31 Next Tail

10 Items Per Page (Page 28 / 151) Total 1504 Items

©copyright 2009-2020 Jew Daily       Contact Us   SiteMap